MAXONIQ is a company that specializes in designing and manufacturing custom cranio-maxillofacial surgical devices. Founded in 2016 and headquartered in Australia, the company aims to revolutionize the field of cranio-maxillofacial surgery with its innovative products.
The company's mission is to become a global leader in the development of groundbreaking surgical solutions, particularly in the area of complex oral and maxillofacial applications. MAXONIQ's product range includes a TMJ Total Joint Replacement System, 3D printed oral and maxillofacial devices such as Custom Plates, Biomodels, custom surgical Splints and Guides, and the innovative OsseoFrame™ implantable device.
MAXONIQ's commitment to innovation and its embrace of the 3D printing digital revolution set it apart in the Health Care and Medical Devices industries. The company's core focus on patient-specific functional solutions highlights its dedication to improving the quality of care in cranio-maxillofacial surgery.
Although specific details about the company's latest investment and investors are not available at the moment, MAXONIQ's pioneering approach and its potential to redefine the standards of cranio-maxillofacial surgery make it an intriguing prospect for venture capital firms and investors seeking opportunities in the medical technology sector.